Harmony Biosciences Inc.

AI Score

0

Unlock

36.42
0.00 (0.00%)
At close: Jan 15, 2025, 12:49 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio 14.91 17.97 70.91 -39.66 -14.91 -45.68
PS Ratio 3.30 7.45 8.03 12.87 393.12 n/a
PB Ratio 4.11 8.09 13.15 21.16 -203.43 22.35
P/FCF Ratio 8.77 31.26 -1.41K -412.39 -11.63 -45.4
P/OCF Ratio 8.76 22.57 24.89 -688.98 -31.24 -46.97
OCF/S Ratio 0.38 0.33 0.32 -0.02 -12.58 n/a
Debt / Equity Ratio 0.41 0.48 1.03 2.00 -8.45 3.98
Quick Ratio 2.72 5.02 5.21 1.93 1.53 11.99
Current Ratio 2.75 5.07 5.29 1.95 1.58 11.99
Asset Turnover 0.72 0.65 0.70 0.37 0.06 n/a
Interest Coverage 8.08 7.67 2.87 0.13 -24.03 n/a
Return on Equity (ROE) 0.28 0.45 0.19 -0.53 13.64 -0.49
Return on Assets (ROA) 0.16 0.27 0.08 -0.12 -1.48 -0.45
Return on Capital (ROIC) 0.30 0.20 0.18 0.01 -1.68 -0.51
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 79.17% 80.93% 81.82% 82.64% 73.69% n/a
Net Profit Margin 22.14% 41.44% 11.33% -32.46% -2.64K% n/a
Pretax Profit Margin 29.79% 23.91% 12.25% -23.13% -2.54K% n/a
Operating Profit Margin 32.99% 27.45% 22.49% 2.30% -2.43K% n/a
FCF Margin 37.64% 23.82% -0.57% -3.12% -3.38K% n/a
EBITDA Margin 38.06% 32.79% 34.82% 0.95% -2.38K% n/a